Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea · Delayed Price · Currency is KRW 5,520.00
-90.00 (-1.60%)
At close: Oct 23, 2026
Keeps Biopharma Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 220,477 | 170,147 | 127,583 | 92,133 | 14,617 | 4,261 |
Revenue Growth | 48.61% | 33.36% | 38.48% | 530.30% | 243.09% | -72.00% |
Gross Profit Gross Profit Growth | 39,549 | 37,576 | 17,240 | 12,798 | 1,044 | -788.97 |
Operating Income Operating Income Growth | -598.9 | 1,575 | 6,225 | 3,060 | -8,915 | -12,307 |
Net Income Net Income Growth | -12,389 | -9,785 | 1,113 | 3,930 | -11,375 | -15,317 |
Earnings Per Share EPS Growth | -619.29 | -499.00 | 59.00 | 209.00 | -607.03 | -884.60 |
EPS Growth | - | - | -71.77% | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Bio Business Division Bio Business Division Growth | 67,865 | 49,215 | 10,021 | 6,389 |
Recycling Recycling Growth | 147,268 | 115,607 | 112,613 | 81,628 |
OLED Business OLED Business Growth | 10,338 | 8,351 | 5,772 | 4,585 |
Inter-segmental Inter-segmental Growth | -4,994 | -3,027 | -822.15 | -468.46 |
Total Total Growth | 220,477 | 170,147 | 127,583 | 92,133 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 28,987 | 26,571 | 22,988 | 10,910 | 25,203 | 40,889 |
Total Debt Total Debt Growth | 95,260 | 92,593 | 55,737 | 48,304 | 28,820 | 27,603 |
Net Cash (Debt) Net Cash Growth | -66,274 | -66,022 | -32,749 | -37,395 | -3,617 | 13,286 |
Net Cash Growth | - | - | - | - | - | 21.17% |
Net Cash Per Share Net Cash Per Share Growth | -3311.80 | -3365.52 | -1734.17 | -1987.66 | -193.02 | 767.26 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -11,577 | -14,921 | 4,808 | -57.13 | -866.26 | -8,380 |
Capital Expenditures CapEx Growth | -32,191 | -31,933 | -6,596 | -990.97 | -95.85 | -90.75 |
Free Cash Flow Free Cash Flow Growth | -43,768 | -46,854 | -1,787 | -1,048 | -962.12 | -8,471 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 17.94% | 22.09% | 13.51% | 13.89% | 7.14% | -18.52% |
Operating Margin | -0.27% | 0.92% | 4.88% | 3.32% | -60.99% | -288.86% |
Pretax Margin | -6.22% | -6.88% | 2.64% | 5.83% | -94.94% | -406.17% |
Profit Margin | -5.62% | -5.75% | 0.87% | 4.27% | -77.82% | -359.52% |
FCF Margin | -19.85% | -27.54% | -1.40% | -1.14% | -6.58% | -198.82% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 87.73 | 30.53 | - | - |
Forward PE | - | 16.78 | 3.21 | 3.21 | 3.21 | 3.21 |
PS Ratio | 0.50 | 1.23 | 0.77 | 1.30 | 8.75 | 55.30 |